Supplementary Figure from Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Maria R. Baer,Aksinija A. Kogan,Søren M. Bentzen,Tian Mi,Rena G. Lapidus,Vu H. Duong,Ashkan Emadi,Sandrine Niyongere,Casey L. O'Connell,Benjamin A. Youngblood,Stephen B. Baylin,Feyruz V. Rassool

crossref（2023）

引用 10|浏览15

暂无评分

摘要

Supplementary Figure from Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要